Healthcare AI Governance Consulting

When the informal path no longer holds

This work may fit when:

• AI requests and pilots are tracked in different places or not at all;

• a committee can discuss issues but lacks a consistent intake, decision, or follow-through method;

• one visible use case is moving toward implementation and needs named reviewers, owners, measures, and stopping rules;

• deployed tools need a review and monitoring cadence; or

• leaders need an inventory and decision record they can inspect without slowing every request equally.

The work needs an executive sponsor, a client operating owner, access to the current request and vendor landscape, and qualified client reviewers for clinical, legal, privacy, security, data, and regulatory decisions as applicable.

It is not a fit when the buyer wants a generic policy file, an automatic approval, a certification, or a guarantee that a model is safe, compliant, unbiased, effective, or valuable.

What the program leaves behind

The initial scope selects only the artifacts needed for the buyer's starting point.

• AI inventory and ownership register: use case, sponsor, purpose, users, vendor/model, data, environment, status, and accountable owner.

• Intake and triage form: the minimum information needed to route a request without making every use case complete a maximum-burden review.

• Risk and review rubric: scoped criteria that determine which reviewers, evidence, and approval path a use case needs.

• Decision-rights map: who recommends, reviews, decides, implements, monitors, escalates, and may stop use.

• Decision and exception record: the question, evidence, reviewers, disposition, conditions, open risks, and next review.

• Implementation and adoption plan: workflow changes, technical dependencies, training, communication, readiness, acceptance, and operating ownership.

• Monitoring register: approved measures, data source, owner, cadence, threshold, investigation path, and retirement/review trigger.

• Operating calendar and handoff: recurring reviews, portfolio reporting, unresolved decisions, document ownership, and update process.

These are applied work products, not evidence that IT Modality has delivered a client program or produced an outcome.

Begin with a bounded install

1. Frame. Name the sponsor, prioritized use case or portfolio boundary, decision owners, current process, data/access constraints, and success evidence for the stage.

2. Inventory. Build the current register, identify missing ownership and evidence, and separate known facts from unresolved questions.

3. Triage and decide. Apply the agreed rubric, route reviews, document conditions and exceptions, and define the implementation gate.

4. Implement one path. Move one approved use case or request class through workflow design, technical work, readiness, acceptance, and operating ownership.

5. Monitor and transfer. Establish the review cadence, threshold/escalation path, document owners, and a stop, expand, or handoff decision.

The engagement does not expand because a stage sounds promising. Expansion follows an explicit decision using the evidence, constraints, and unresolved risks from the bounded stage.

See the complete delivery method

Put the decision with the right owner

Client sponsor sets the program mandate, assigns decision authority, resolves organizational blockers, and owns the business decision.

Client operating owner maintains the portfolio, convenes reviews, follows conditions, and carries the program after handoff.

Clinical or physician reviewer, when required evaluates the use case within an approved role and evidence set. That role does not replace the client's clinical governance or establish a clinical conclusion by title alone.

Privacy, security, legal, data, and regulatory reviewers retain their assigned specialist decisions. IT Modality organizes questions and evidence; it does not overrule their scope.

IT Modality delivery lead and project/program manager, when the roles are staffed and approved maintain scope, decisions, dependencies, reporting, escalation, and handoff.

Technical and quality-assurance roles, when included implement and test the approved work against defined criteria. A passing gate means the agreed evidence was reviewed; it is not a universal safety or compliance claim.

Client inputs can include the current portfolio/request list, existing policies, vendor materials, data-flow and architecture context, workflow owners, specialist review requirements, training context, incident/issue history, and approved access to the selected work.

Governance does not remove uncertainty

The scope excludes legal, clinical, privacy, security, or regulatory conclusions unless a separately qualified and authorized specialist owns that decision. It also excludes automatic vendor approval, enterprise-wide implementation beyond the agreed use case, and any promise of adoption, return, safety, accuracy, bias reduction, or clinical outcome.

Pause or stop when:

• no sponsor or operating owner can make and maintain decisions;

• required reviewers cannot participate or will not accept the decision role;

• the use case, data flow, intended user, or product claim cannot be described well enough to scope;

• access or evidence would violate an approved boundary;

• the vendor or internal owner cannot supply material information;

• implementation conditions remain unresolved at the decision gate; or

• the organization wants a policy label without operating ownership.

AI governance questions

We already have an AI committee. What changes?

A committee may remain the decision forum. The work here makes its operating path explicit: intake, portfolio record, triage, evidence, decision rights, conditions, implementation ownership, monitoring, exceptions, and follow-through.

Can you tell us whether an AI product is safe or compliant?

No. The program can structure the questions, evidence, reviewers, conditions, and decision record. Qualified client and specialist reviewers retain clinical, legal, privacy, security, product, and regulatory conclusions.

Do we need to start with the entire portfolio?

No. A bounded start can focus on an inventory and triage install, one request class, or one use case moving toward implementation. The stage ends with a stop, expand, or handoff decision.

Do you select AI vendors?

Vendor comparison can be one scoped input, but no page or rubric replaces procurement, contracting, technical validation, workflow review, or specialist diligence. The buyer retains the selection decision.

What does monitoring mean?

The engagement defines the measures, source, owner, cadence, thresholds, review path, and response decision appropriate to the use case. It does not promise that every issue can be predicted or prevented.

Public rates are not published. Contact us for pricing after the portfolio boundary, starting stage, roles, implementation scope, specialist inputs, operating cadence, and client responsibilities are understood.

Bring one use case or one portfolio problem

Share the current decision path, sponsor, use case or portfolio boundary, known reviewers, and what must happen next. The inquiry helps determine whether a bounded inventory, triage, implementation, or operating-cadence stage fits. It does not create approval, scope, availability, price, or response-time commitments.

Discuss an AI governance program